| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |